NEW YORK, Sept. 11, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 http://www.reportlinker.com/p01623033/EpiCast-Report-Overweight-and-Obesity---Epidemiology-Forecast-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

Summary

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health. As obesity is a complex condition associated with a wide range of lifestyle, genetic, social, cultural, and environmental factors, its prevalence may vary across countries, depending on the variations in these contributing factors.

GlobalData's epidemiological analysis forecasts that prevalent cases of overweight in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase from 250.05 million in 2012 to 271.86 million cases in 2022 at an annual growth rate (AGR) of 0.86%. Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in 2012 were in men. GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR of 2.75%. Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012 were in women.

According to GlobalData's forecast, the prevalent cases of both overweight and obesity will increase dramatically over the next decade, with the number of obese adults increasing by an alarming 27.50%. Overweight and obesity have reached pandemic proportions; however, GlobalData epidemiologists believe that with the alarming increase in the prevalence of both overweight and obesity, the morbidity and mortality associated with the disease will continue to increase dramatically as well.

Scope

- The Overweight and Obesity EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of overweight and obesity in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada). It includes a 10-year epidemiology forecast of the prevalent cases of overweight, obesity, obesity class I, obesity class II, and obesity class III segmented by sex and age. In addition, the report includes a 10-year forecast of the prevalent cases of obesity-associated comorbidities, including diagnosed diabetes, diagnosed hypertension, and dyslipidemia, among adults with overweight/obesity in some of these markets.- The overweight and obesity epidemiology report is written and developed by Masters- and PhD-level epidemiologists.- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global overweight and obesity market. - Quantify patient populations in the global overweight and obesity market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered. - Identify the number of obesity class I, obesity class II, and obesity class III prevalent cases.1 Table of Contents1 Table of Contents 41.1 List of Tables 71.2 List of Figures 82 Introduction 102.1 Catalyst 102.2 Related Reports 113 Epidemiology 123.1 Disease Overview 123.2 Risk Factors and Comorbidities 133.2.1 Family history is a strong predictor of obesity 133.2.2 Physical inactivity is an independent predictor of obesity 143.2.3 Excessive caloric intake doubles the risk for obesity 153.2.4 Hypertension is as high as 42% in obese adults 163.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients 173.3 Global Trends 193.3.1 US 203.3.2 5EU 223.3.3 Japan 283.3.4 Brazil 293.3.5 Canada 313.4 Forecast Methodology 323.4.1 Sources Used 393.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by Class, and Comorbidities 463.4.3 Sources Not Used 633.5 Epidemiology Forecast of Overweight (2012–2022) 633.5.1 Prevalent Cases of Overweight 633.5.2 Age-Specific Prevalent Cases of Overweight 653.5.3 Sex-Specific Prevalent Cases of Overweight 673.5.4 Age-Standardized Prevalence of Overweight 703.6 Epidemiology Forecast of Obesity (2012–2022) 713.6.1 Prevalent Cases of Obesity 713.6.2 Age-Specific Prevalent Cases of Obesity 733.6.3 Sex-Specific Prevalent Cases of Obesity 753.6.4 Age-Standardized Prevalence of Obesity 763.7 Epidemiology Forecast of Obesity Class I (2012–2022) 773.7.1 Prevalent Cases of Obesity Class I 773.7.2 Age-Specific Prevalent Cases of Obesity Class I 793.7.3 Sex-Specific Prevalent Cases of Obesity Class I 813.7.4 Age-Standardized Prevalence of Obesity Class I 833.8 Epidemiology Forecast of Obesity Class II (2012–2022) 853.8.1 Prevalent Cases of Obesity Class II 853.8.2 Age-Specific Prevalent Cases of Obesity Class II 873.8.3 Sex-Specific Prevalent Cases of Obesity Class II 893.8.4 Age-Standardized Prevalence of Obesity Class II 913.9 Epidemiology Forecast of Obesity Class III (2012–2022) 933.9.1 Prevalent Cases of Obesity Class III 933.9.2 Age-Specific Prevalent Cases of Obesity Class III 953.9.3 Sex-Specific Prevalent Cases of Obesity Class III 973.9.4 Age-Standardized Prevalence of Obesity Class III 993.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and 2022) 1013.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity 1013.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity 1043.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity 1063.11 Discussion 1093.11.1 Conclusions on Epidemiological Trends 1093.11.2 Limitations of the Analysis 1103.11.3 Strengths of the Analysis 1114 Appendix 1124.1 Bibliography 1124.2 About the Authors 1184.2.1 Epidemiologists 1184.2.2 Reviewers 1184.2.3 Global Director of Epidemiology and Health Policy 1194.2.4 Global Head of Healthcare 1204.3 About GlobalData 1214.4 About EpiCast 1214.5 Disclaimer 1211.1 List of Tables

Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI 12Table 2: Risk Factors and Comorbidities of Obesity 13Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ?20 Years, 2008 20Table 4: JASSO and WHO Classifications of Obesity 28Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight 33Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity 34Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I, Class II, and Class III 36Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in Overweight/Obese 38Table 9: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 64Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012 66Table 11: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 68Table 12: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 72Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 74Table 14: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), Row (%), 2012 75Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 78Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 80Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 82Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 86Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 88Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 90Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 94Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 96Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 98Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 102Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 105Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 1071.2 List of Figures

Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–2010 21Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–2010 21Figure 3: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Men, 1997–2006 23Figure 4: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Women, 1997–2006 23Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Men, 1993–2011 27Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Women, 1993–2011 27Figure 9: Japan, Obesity Prevalence (%), Ages ?20 Years, By Sex, 1976–2006 29Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Men, 1975–2003 30Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Women, 1975–2003 30Figure 12: Canada, Obesity Prevalence (%), Ages ?18 Years, Both Sexes, 1978–2008 32Figure 13: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 65Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 67Figure 15: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, by Sex, N (Millions), 2012 69Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 71Figure 17: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 73Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 74Figure 19: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), 2012 76Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 77Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 79Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 81Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, by Sex, N (Millions), 2012 83Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ?18 Years, by Sex, 2012 84Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 87Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 89Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, by Sex, N (Millions), 2012 91Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ?18 Years, By Sex, 2012 92Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 95Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 97Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), 2012 99Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 100Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 103Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 106Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 108

To order this report: EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 http://www.reportlinker.com/p01623033/EpiCast-Report-Overweight-and-Obesity---Epidemiology-Forecast-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker

RELATED LINKShttp://www.reportlinker.com